Physician profile
Cary Hirsch
NPI 1215965298
$12,545.06
in general payments reported to CMS, 2019-2025
39 companies · $691 in 2025
The $691 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,596 · 2020: $1,148 · 2021: $210 · 2022: $196 · 2023: $329 · 2024: $374 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.83 |
| Education | $127.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,849.39 | 2019-2024 | |
| Abbott Laboratories | $1,301.34 | 2019-2024 | Portico |
| Amgen INC. | $1,205.37 | 2019-2021 | |
| Boston Scientific Corporation | $629.80 | 2019-2025 | Farapulse, Watchman Access System, Emblem Mri S-Icd |
| Abiomed | $453.11 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $332.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $257.33 | 2019-2020 | |
| Pfizer INC. | $255.80 | 2019-2021 | |
| Medtronic Vascular, INC. | $243.97 | 2019-2020 | |
| Bridgebio Pharma, INC. | $230.53 | 2025 | Attruby |
| Medtronic, INC. | $222.38 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $213.44 | 2019-2023 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $137.52 | 2023 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $94.99 | 2024 | Opsumit, Uptravi |
| Atricure, INC. | $92.58 | 2023-2024 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.